Thanks Wiz, for telling us your story.

It seems that a lot of us have been disappointed in the ABCRs and a few of us are satisfied with them. That, to me, shows that the 35% success ratio is right on target.

Good luck with the Tysabri. I think it has a better track record for keeping exacerbations at bay. Vlys just reported...no exacerbaions in 7 months, on Tysabri...woooooohoooooo.

Keep us posted, Wiz.